| Mark P. Mattson | |
|---|---|
| Photo placeholder | |
| Affiliations | NIH NIA |
| Country | USA |
| H-index | 250 |
| ORCID | 0000-0003-2129-2289 |
| Research Focus | Alzheimer's Disease, Parkinson's Disease |
| Mechanisms | Apoptosis, Calorie restriction, Mitochondrial dysfunction |
Mark P. Mattson is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Mark P. Mattson is a leading researcher in the field of neurodegenerative diseases, affiliated with NIH and NIA. Their research focuses on Apoptosis, Calorie restriction, Mitochondrial dysfunction, with particular emphasis on Alzheimer's Disease and Parkinson's Disease. With an h-index of 250, Mattson is among the most cited researchers in the neuroscience field.
Mattson's work spans multiple aspects of neurodegeneration, contributing to our understanding of the molecular mechanisms that underlie diseases such as Alzheimer's Disease and Parkinson's Disease.
Dr. Mark Mattson is one of the most influential neuroscientists in the field of neurodegeneration, known for his pioneering work on the molecular mechanisms of neuronal death and the role of energy metabolism in brain health.
Apoptosis and Neurodegeneration: Dr. Mattson's laboratory was among the first to characterize the pathways by which neurons undergo apoptosis in response to various insults, revealing targets for neuroprotective therapies.
Calorie Restriction and Intermittent Fasting: His groundbreaking research has demonstrated that calorie restriction and intermittent fasting can enhance brain health and protect against neurodegenerative processes, influencing the field of lifestyle interventions for brain health.
Mitochondrial Dysfunction: His work has elucidated how mitochondrial dysfunction contributes to neuronal death in Alzheimer's and Parkinson's diseases, revealing therapeutic targets.
Neurotrophic Factors: Research on brain-derived neurotrophic factor (BDNF) and other growth factors that support neuron survival and plasticity.
Hormesis and Cellular Stress Response: Understanding how mild stress activates protective cellular mechanisms.
Dr. Mattson has made transformative contributions to neuroscience:
Intermittent Fasting Research: His studies have established intermittent fasting as a powerful intervention for improving cognitive function and reducing Alzheimer's and Parkinson's disease risk in both animal models and human studies.
Hormesis: Contributed to understanding how mild cellular stress can activate protective mechanisms that make neurons more resilient to severe insults.
Translational Research: Bridged basic science discoveries to clinical applications, including lifestyle-based interventions for brain health.
Neuroprotection Strategies: Identified multiple pathways for protecting neurons against various insults.
His research has had profound clinical implications:
With over 400 publications, Dr. Mattson has authored influential papers on:
Dr. Mattson's pioneering contributions have been recognized with numerous awards, including leadership positions at the National Institute on Aging where he has shaped the direction of aging and neurodegeneration research.
The study of Mark P. Mattson has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.